Key Points
-
During cold exposure, human bodies attempt to maintain core temperature by reducing heat loss via cutaneous vasoconstriction and by increasing heat production via shivering and nonshivering thermogenesis
-
In selected skin areas, nutritional capillaries are bypassed by arteriovenous anastomoses; these thermoregulatory structures are predominantly closed during heat conservation and fully dilated during heat elimination
-
Cold exposure activates and amplifies sympathetic nervous system signalling, triggering cutaneous vasoconstriction and thermogenesis: sympathetic vasoconstriction selectively restricts blood flow through arteriovenous anastomoses while protecting nutritional capillary blood flow
-
In Raynaud phenomenon, the already heightened sympathetic vasoconstriction in areas rich in arteriovenous anastomoses is further amplified in intensity and scope, with expansion into the adjoining nutritional system
-
Cold-induced vasospasm and interruption of capillary blood flow is mediated by sympathetic vasoconstriction, and modulation by endothelial vasodilatation perhaps contributes to differences between primary and secondary forms of Raynaud phenomenon
-
Despite the exuberant increase in cold-induced vasoconstriction in Raynaud phenomenon, reflecting upregulation of heat-conservation mechanisms, surprisingly little is known about thermogenesis in this disorder
Abstract
During exposure to cold, our bodies attempt to maintain normal core temperature by restricting heat loss through cutaneous vasoconstriction, and by increasing heat production through shivering and nonshivering thermogenesis. In selected areas of human skin (including on the fingers and toes), the vascular system has specialized structural and functional features that enable it to contribute to thermoregulation. These features include arteriovenous anastomoses, which directly connect the arterial and venous systems and bypass the nutritional capillaries supplying blood to the skin tissue. Of note, Raynaud phenomenon predominantly affects the arterial territories supplying these specialized areas of skin. Indeed, Raynaud phenomenon can be considered a disorder of vascular thermoregulatory control. This Review presents an understanding of Raynaud phenomenon in the context of vascular and thermoregulatory control mechanisms, including the role of unique thermosensitive vascular structural and functional specialization, and describes the potential role of thermogenesis in this disorder. This new approach provides remarkable insight into the disease process and builds a framework to critically appraise the existing knowledge base. This paradigm also explains the deficiencies in some current therapeutic approaches, and highlights new areas of potential relevance to the pathogenesis and treatment of Raynaud phenomenon that should be expanded and explored.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Burton, A. C. The range and variability of the blood flow in the human fingers and the vasomotor regulation by body temperature. Am. J. Physiol. 127, 437–453 (1939).
Charkoudian, N. Mechanisms and modifiers of reflex induced cutaneous vasodilation and vasoconstriction in humans. J. Appl. Physiol. (1985) 109, 1221–1228 (2010).
Herrick, A. L. The pathogenesis, diagnosis and treatment of Raynaud phenomenon. Nat. Rev. Rheumatol. 8, 469–479 (2012).
LeRoy, E. C. & Medsger, T. A. Jr. Raynaud's phenomenon: a proposal for classification. Clin. Exp. Rheumatol. 10, 485–488 (1992).
Maverakis, E. et al. International consensus criteria for the diagnosis of Raynaud's phenomenon. J. Autoimmun. 48–49, 60–65 (2014).
Taylor, G. I. in Grabb and Smith's Plastic Surgery (eds. Thorne, C. H. et al.) 33–41 (Lippincott, Williams & Wilkins, 2007).
Braverman, I. M. The cutaneous microcirculation. J. Investig. Dermatol. Symp. Proc. 5, 3–9 (2000).
Sangiorgi, S. et al. Microvascularization of the human digit as studied by corrosion casting. J. Anat. 204, 123–131 (2004).
Thoresen, M. & Walloe, L. Skin blood flow in humans as a function of environmental temperature measured by ultrasound. Acta Physiol. Scand. 109, 333–341 (1980).
Lossius, K., Eriksen, M. & Walloe, L. Fluctuations in blood flow to acral skin in humans: connection with heart rate and blood pressure variability. J. Physiol. 460, 641–655 (1993).
Manelli, A. et al. Plexiform vascular structures in the human digital dermal layer: a SEM corrosion casting morphological study. Eur. J. Morphol. 42, 173–177 (2005).
Bergersen, T. K., Eriksen, M. & Walloe, L. Local constriction of arteriovenous anastomoses in the cooled finger. Am. J. Physiol. 273, R880–R886 (1997).
Bergersen, T. K., Hisdal, J. & Walloe, L. Perfusion of the human finger during cold-induced vasodilatation. Am. J. Physiol. 276, R731–R737 (1999).
Bini, G., Hagbarth, K. E., Hynninen, P. & Wallin, B. G. Regional similarities and differences in thermoregulatory vaso- and sudomotor tone. J. Physiol. 306, 553–565 (1980).
Kellogg, D. L. Jr et al. Cutaneous active vasodilation in humans is mediated by cholinergic nerve cotransmission. Circ. Res. 77, 1222–1228 (1995).
Nakamura, K. Central circuitries for body temperature regulation and fever. Am. J. Physiol. Regul. Integr. Comp. Physiol. 301, R1207–R1228 (2011).
Morrison, S. F. 2010 Carl Ludwig Distinguished Lectureship of the APS Neural Control and Autonomic Regulation Section: central neural pathways for thermoregulatory cold defence. J. Appl. Physiol. (1985) 110, 1137–1149 (2011).
Flavahan, N. A., Lindblad, L. E., Verbeuren, T. J., Shepherd, J. T. & Vanhoutte, P. M. Cooling and α1- and α2-adrenergic responses in cutaneous veins: role of receptor reserve. Am. J. Physiol. 249, H950–H955 (1985).
Honda, M., Suzuki, M., Nakayama, K. & Ishikawa, T. Role of α2C-adrenoceptors in the reduction of skin blood flow induced by local cooling in mice. Br. J. Pharmacol. 152, 91–100 (2007).
Sawasaki, N., Iwase, S. & Mano, T. Effect of skin sympathetic response to local or systemic cold exposure on thermoregulatory functions in humans. Autonom. Neurosci. 87, 274–281 (2001).
Ootsuka, Y. & McAllen, R. M. Comparison between two rat sympathetic pathways activated in cold defence. Am. J. Physiol. Regul. Integr. Comp. Physiol. 291, R589–R595 (2006).
Bini, G., Hagbarth, K. E., Hynninen, P. & Wallin, B. G. Thermoregulatory and rhythm-generating mechanisms governing the sudomotor and vasoconstrictor outflow in human cutaneous nerves. J. Physiol. 306, 537–552 (1980).
Coffman, J. D. Total and nutritional blood flow in the finger. Clin. Sci. 42, 243–250 (1972).
Hertzman, A. B. Vasomotor regulation of cutaneous circulation. Physiol. Rev. 39, 280–306 (1959).
McCook, R. D., Wurster, R. D. & Randall, W. C. Sudomotor and vasomotor responses to changing environmental temperature. J. Appl. Physiol. 20, 371–378 (1965).
Montgomery, L. D. & Williams, B. A. Variation of forearm, hand, and finger blood flow indices with ambient temperature. Aviat. Space Environ. Med. 48, 231–235 (1977).
Coffman, J. D. & Cohen, A. S. Total and capillary fingertip blood flow in Raynaud's phenomenon. N. Engl. J. Med. 285, 259–263 (1971).
Saad, A. R. et al. Influence of isometric exercise on blood flow and sweating in glabrous and nonglabrous human skin. J. Appl. Physiol. (1985) 91, 2487–2492 (2001).
Richardson, D., Schmitz, M. & Borchers, N. Relative effects of static muscle contraction on digital artery and nailfold capillary blood flow velocities. Microvasc. Res. 31, 157–169 (1986).
Haak, E. et al. The impact of contralateral cooling on skin capillary blood cell velocity in patients with diabetes mellitus. J. Vasc. Res. 35, 245–249 (1998).
Halperin, J. L., Cohen, R. A. & Coffman, J. D. Digital vasodilatation during mental stress in patients with Raynaud's disease. Cardiovasc. Res. 17, 671–677 (1983).
Kristensen, J. K., Engelhart, M. & Nielsen, T. Laser-Doppler measurement of digital blood flow regulation in normals and in patients with Raynaud's phenomenon. Acta Derm. Venereol. 63, 43–47 (1983).
Engelhart, M. & Kristensen, J. K. Raynaud's phenomenon: blood supply to fingers during indirect cooling, evaluated by laser Doppler flowmetry. Clin. Physiol. 6, 481–488 (1986).
Smyth, A. E., Bell, A. L., Bruce, I. N., McGrann, S. & Allen, J. A. Digital vascular responses and serum endothelin-1 concentrations in primary and secondary Raynaud's phenomenon. Ann. Rheum. Dis. 59, 870–874 (2000).
Cooke, J. P. et al. Role of digital artery adrenoceptors in Raynaud's disease. Vasc. Med. 2, 1–7 (1997).
Greenstein, D., Gupta, N. K., Martin, P., Walker, D. R. & Kester, R. C. Impaired thermoregulation in Raynaud's phenomenon. Angiology 46, 603–611 (1995).
Terregino, C. A. & Seibold, J. R. Influence of the menstrual cycle on Raynaud's phenomenon and on cold tolerance in normal women. Angiology 36, 88–95 (1985).
LeRoy, E. C., Downey, J. A. & Cannon, P. J. Skin capillary blood flow in scleroderma. J. Clin. Invest. 50, 930–939 (1971).
Maricq, H. R., Downey, J. A. & LeRoy, E. C. Standstill of nailfold capillary blood flow during cooling in scleroderma and Raynaud's syndrome. Blood Vessels 13, 338–349 (1976).
Recio, P. et al. Noradrenergic vasoconstriction of pig prostatic small arteries. Naunyn Schmiedebergs Arch. Pharmacol. 376, 397–406 (2008).
Flavahan, N. A. Phenylpropanolamine constricts mouse and human blood vessels by preferentially activating α2-adrenoceptors. J. Pharmacol. Exp. Ther. 313, 432–439 (2005).
Flavahan, N. A. The role of α2-adrenoceptors as cutaneous thermosensors. News Physiol. Sci. 6, 251–255 (1991).
Flavahan, N. A. & Vanhoutte, P. M. Effect of cooling on α-1 and α-2 adrenergic responses in canine saphenous and femoral veins. J. Pharmacol. Exp. Ther. 238, 139–147 (1986).
Chotani, M. A. et al. Regulation of α2-adrenoceptors in human vascular smooth muscle cells. Am. J. Physiol. Heart Circ. Physiol. 286, H59–H67 (2004).
Flavahan, N. A., Cooke, J. P., Shepherd, J. T. & Vanhoutte, P. M. Human postjunctional α-1 and α-2 adrenoceptors: differential distribution in arteries of the limbs. J. Pharmacol. Exp. Ther. 241, 361–365 (1987).
Chotani, M. A. & Flavahan, N. A. Intracellular α2C-adrenoceptors: storage depot, stunted development or signalling domain? Biochim. Biophys. Acta 1813, 1495–1503 (2011).
Flavahan, N. A., Rimele, T. J., Cooke, J. P. & Vanhoutte, P. M. Characterization of postjunctional α-1 and α-2 adrenoceptors activated by exogenous or nerve-released noradrenaline in the canine saphenous vein. J. Pharmacol. Exp. Ther. 230, 699–705 (1984).
Coffman, J. D. & Cohen, R. A. Role of α-adrenoceptor subtypes mediating sympathetic vasoconstriction in human digits. Eur. J. Clin. Invest. 18, 309–313 (1988).
Coffman, J. D. & Cohen, R. A. α2-adrenergic and 5-HT2 receptor hypersensitivity in Raynaud's phenomenon. J. Vasc. Med. Biol. 2, 100–106 (1990).
Fagius, J. & Blumberg, H. Sympathetic outflow to the hand in patients with Raynaud's phenomenon. Cardiovasc. Res. 19, 249–253 (1985).
Freedman, R. R., Sabharal, S. C., Desai, N., Wenig, P. & Mayes, M. Increased α-adrenergic responsiveness in idiopathic Raynaud's disease. Arthritis Rheum. 32, 61–65 (1989).
Freedman, R. R., Moten, M., Migaly, P. & Mayes, M. Cold-induced potentiation of α 2-adrenergic vasoconstriction in primary Raynaud's disease. Arthritis Rheum. 36, 685–690 (1993).
Flavahan, N. A. et al. Increased α2-adrenergic constriction of isolated arterioles in diffuse scleroderma. Arthritis Rheum. 43, 1886–1890 (2000).
Carter, S. A., Dean, E. & Kroeger, E. A. Apparent finger systolic pressures during cooling in patients with Raynaud's syndrome. Circulation 77, 988–996 (1988).
Jamieson, G. G., Ludbrook, J. & Wilson, A. Cold hypersenstivity in Raynaud's phenomenon. Circulation 44, 254–264 (1971).
Bollinger, A. & Schlumpf, M. Finger blood flow in healthy subjects of different age and sex and in patients with primary Raynaud's disease. Acta Chir. Scand. Suppl. 465, 42–47 (1976).
Nuzzaci, G. et al. Arteriovenous anastomoses' function and Raynaud's phenomenon. Angiology 39, 812–818 (1988).
Singh, S., de Trafford, J. C., Baskerville, P. A. & Roberts, V. C. Digital artery calibre measurement—a new technique of assessing Raynaud's phenomenon. Eur. J. Vasc. Surg. 5, 199–203 (1991).
Naidu, S., Baskerville, P. A., Goss, D. E. & Roberts, V. C. Raynaud's phenomenon and cold stress testing: a new approach. Eur. J. Vasc. Surg. 8, 567–573 (1994).
Chotani, M. A., Flavahan, S., Mitra, S., Daunt, D. & Flavahan, N. A. Silent α2C-adrenergic receptors enable cold-induced vasoconstriction in cutaneous arteries. Am. J. Physiol. Heart Circ. Physiol. 278, H1075–H1083 (2000).
Thompson-Torgerson, C. S., Holowatz, L. A., Flavahan, N. A. & Kenney, W. L. Cold-induced cutaneous vasoconstriction is mediated by Rho kinase in vivo in human skin. Am. J. Physiol. Heart Circ. Physiol. 292, H1700–H1705 (2007).
Bailey, S. R., Eid, A. H., Mitra, S., Flavahan, S. & Flavahan, N. A. Rho kinase mediates cold-induced constriction of cutaneous arteries: role of α2C-adrenoceptor translocation. Circ. Res. 94, 1367–1374 (2004).
Bailey, S. R., Mitra, S., Flavahan, S. & Flavahan, N. A. Reactive oxygen species from smooth muscle mitochondria initiate cold-induced constriction of cutaneous arteries. Am. J. Physiol. Heart Circ. Physiol. 289, H243–H250 (2005).
Freedman, R. R., Baer, R. P. & Mayes, M. D. Blockade of vasospastic attacks by α2-adrenergic but not α1-adrenergic antagonists in idiopathic Raynaud's disease. Circulation 92, 1448–1451 (1995).
Fleming, I. Molecular mechanisms underlying the activation of eNOS. Pflugers Arch. 459, 793–806 (2010).
Ringqvist, A., Jonason, T., Leppert, J. & Ringqvist, I. Non-invasive investigation of endothelium-dependent dilatation of the brachial artery in women with primary Raynaud's phenomenon. Clin. Sci. (Lond.) 94, 239–243 (1998).
Marasini, B. & Conciato, L. Iontophoretic evaluation of vascular reactivity to acetylcholine in patients with primary Raynaud's phenomenon and systemic sclerosis. Clin. Rheumatol. 20, 451–452 (2001).
Anderson, M. E., Moore, T. L., Lunt, M. & Herrick, A. L. Digital iontophoresis of vasoactive substances as measured by laser Doppler imaging—a non-invasive technique by which to measure microvascular dysfunction in Raynaud's phenomenon. Rheumatology (Oxford) 43, 986–991 (2004).
Goel, A. et al. Increased endothelial exocytosis and generation of endothelin-1 contributes to constriction of aged arteries. Circ. Res. 107, 242–251 (2010).
Chauhan, A. K. et al. ADAMTS13: a new link between thrombosis and inflammation. J. Exp. Med. 205, 2065–2074 (2008).
Konttinen, Y. T. et al. Vascular damage and lack of angiogenesis in systemic sclerosis skin. Clin. Rheumatol. 22, 196–202 (2003).
Herrick, A. L. et al. Von Willebrand factor, thrombomodulin, thromboxane, β-thromboglobulin and markers of fibrinolysis in primary Raynaud's phenomenon and systemic sclerosis. Ann. Rheum. Dis. 55, 122–127 (1996).
Marasini, B., Cugno, M. & Agostoni, A. Plasma levels of tissue-type plasminogen activator and von Willebrand factor in patients with Raynaud's phenomenon. Arthritis Rheum. 34, 255–256 (1991).
Vancheeswaran, R., Azam, A., Black, C. & Dashwood, M. R. Localization of endothelin-1 and its binding sites in scleroderma skin. J. Rheumatol. 21, 1268–1276 (1994).
Rychlik-Golema, W., Mastej, K. & Adamiec, R. The role of endothelin-1 and selected cytokines in the pathogenesis of Raynaud's phenomenon associated with systemic connective tissue diseases. Int. Angiol. 25, 221–227 (2006).
Vancheeswaran, R. et al. Circulating endothelin-1 levels in systemic sclerosis subsets—a marker of fibrosis or vascular dysfunction? J. Rheumatol. 21, 1838–1844 (1994).
Wigley, F. M. & Herrick, A. L. in Scleroderma: From Pathogenesis to Comprehensive Management (eds Varga, J. et al.) 313–329 (Springer, 2012).
Korn, J. H. et al. Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonist. Arthritis Rheum. 50, 3985–3993 (2004).
Matucci-Cerinic, M. et al. Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial. Ann. Rheum. Dis. 70, 32–38 (2011).
Nguyen, V. A. et al. Effect of the dual endothelin receptor antagonist bosentan on Raynaud's phenomenon secondary to systemic sclerosis: a double-blind prospective, randomized, placebo-controlled pilot study. Rheumatology (Oxford) 49, 583–587 (2010).
Freedman, R. R., Girgis, R. & Mayes, M. D. Abnormal responses to endothelial agonists in Raynaud's phenomenon and scleroderma. J. Rheumatol. 28, 119–121 (2001).
Abou-Raya, A., Abou-Raya, S. & Helmii, M. Statins: potentially useful in therapy of systemic sclerosis-related Raynaud's phenomenon and digital ulcers. J. Rheumatol. 35, 1801–1808 (2008).
Rollando, D. et al. Brachial artery endothelial-dependent flow-mediated dilation identifies early-stage endothelial dysfunction in systemic sclerosis and correlates with nailfold microvascular impairment. J. Rheumatol. 37, 1168–1173 (2010).
Kovacic, J. C., Mercader, N., Torres, M., Boehm, M. & Fuster, V. Epithelial-to-mesenchymal and endothelial-to-mesenchymal transition: from cardiovascular development to disease. Circulation 125, 1795–1808 (2012).
Piera-Velazquez, S., Li, Z. & Jimenez, S. A. Role of endothelial–mesenchymal transition (EndoMT) in the pathogenesis of fibrotic disorders. Am. J. Pathol. 179, 1074–1080 (2011).
Trojanowska, M. Cellular and molecular aspects of vascular dysfunction in systemic sclerosis. Nat. Rev. Rheumatol. 6, 453–460 (2010).
Zeisberg, E. M. et al. Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nat. Med. 13, 952–961 (2007).
Garcia, J. et al. Tie1 deficiency induces endothelial–mesenchymal transition. EMBO Rep. 13, 431–439 (2012).
Widyantoro, B. et al. Endothelial cell-derived endothelin-1 promotes cardiac fibrosis in diabetic hearts through stimulation of endothelial-to-mesenchymal transition. Circulation 121, 2407–2418 (2010).
Basile, D. P. et al. Impaired endothelial proliferation and mesenchymal transition contribute to vascular rarefaction following acute kidney injury. Am. J. Physiol. Renal Physiol. 300, F721–F733 (2011).
Zeisberg, E. M., Potenta, S. E., Sugimoto, H., Zeisberg, M. & Kalluri, R. Fibroblasts in kidney fibrosis emerge via endothelial-to-mesenchymal transition. J. Am. Soc. Nephrol. 19, 2282–2287 (2008).
Maleszewska, M. et al. IL-1β and TGFβ2 synergistically induce endothelial to mesenchymal transition in an NFκB-dependent manner. Immunobiology 218, 443–454 (2013).
Arciniegas, E., Frid, M. G., Douglas, I. S. & Stenmark, K. R. Perspectives on endothelial-to-mesenchymal transition: potential contribution to vascular remodeling in chronic pulmonary hypertension. Am. J. Physiol. Lung Cell. Mol. Physiol. 293, L1–L8 (2007).
Riemekasten, G. et al. Involvement of functional autoantibodies against vascular receptors in systemic sclerosis. Ann. Rheum. Dis. 70, 530–536 (2011).
Stawski, L., Han, R., Bujor, A. M. & Trojanowska, M. Angiotensin II induces skin fibrosis: a novel mouse model of dermal fibrosis. Arthritis Res. Ther. 14, R194 (2012).
Jimenez, S. A. Role of endothelial to mesenchymal transition in the pathogenesis of the vascular alterations in systemic sclerosis. ISRN Rheumatol. 2013, 835948 (2013).
Xu, H. et al. Abnormal fibrillin-1 expression and chronic oxidative stress mediate endothelial mesenchymal transition in a murine model of systemic sclerosis. Am. J. Physiol. Cell. Physiol. 300, C550–C556 (2011).
van Marken Lichtenbelt, W. Brown adipose tissue and the regulation of nonshivering thermogenesis. Curr. Opin. Clin. Nutr. Metab. Care 15, 547–552 (2012).
Tam, C. S., Lecoultre, V. & Ravussin, E. Brown adipose tissue: mechanisms and potential therapeutic targets. Circulation 125, 2782–2791 (2012).
McKemy, D. D. The molecular and cellular basis of cold sensation. ACS Chem. Neurosci. 4, 238–247 (2013).
McCoy, D. D., Knowlton, W. M. & McKemy, D. D. Scraping through the ice: uncovering the role of TRPM8 in cold transduction. Am. J. Physiol. Regul. Integr. Comp. Physiol. 300, R1278–R1287 (2011).
Dhaka, A., Earley, T. J., Watson, J. & Patapoutian, A. Visualizing cold spots: TRPM8-expressing sensory neurons and their projections. J. Neurosci. 28, 566–575 (2008).
Takashima, Y. et al. Diversity in the neural circuitry of cold sensing revealed by genetic axonal labelling of transient receptor potential melastatin 8 neurons. J. Neurosci. 27, 14147–14157 (2007).
Tajino, K. et al. Cooling-sensitive TRPM8 is thermostat of skin temperature against cooling. PLoS ONE 6, e17504 (2011).
Tajino, K. et al. Application of menthol to the skin of whole trunk in mice induces autonomic and behavioural heat-gain responses. Am. J. Physiol. Regul. Integr. Comp. Physiol. 293, R2128–R2135 (2007).
Knowlton, W. M., Daniels, R. L., Palkar, R., McCoy, D. D. & McKemy, D. D. Pharmacological blockade of TRPM8 ion channels alters cold and cold pain responses in mice. PLoS ONE 6, e25894 (2011).
Almeida, M. C. et al. Pharmacological blockade of the cold receptor TRPM8 attenuates autonomic and behavioural cold defences and decreases deep body temperature. J. Neurosci. 32, 2086–2099 (2012).
Chang, L., Milton, H., Eitzman, D. T. & Chen, Y. E. Paradoxical roles of perivascular adipose tissue in atherosclerosis and hypertension. Circ. J. 77, 11–18 (2013).
Chang, L. et al. Loss of perivascular adipose tissue on peroxisome proliferator-activated receptor-γ deletion in smooth muscle cells impairs intravascular thermoregulation and enhances atherosclerosis. Circulation 126, 1067–1078 (2012).
Johnson, C. D. et al. Transient receptor potential melastatin 8 channel involvement in the regulation of vascular tone. Am. J. Physiol. Heart Circ. Physiol. 296, H1868–H1877 (2009).
Greenstein, D., Jeffcote, N., Ilsley, D. & Kester, R. C. The menstrual cycle and Raynaud's phenomenon. Angiology 47, 427–436 (1996).
Wise, R. A. et al. Efficacy and tolerability of a selective α2C-adrenergic receptor blocker in recovery from cold-induced vasospasm in scleroderma patients: a single-center, double-blind, placebo-controlled, randomized crossover study. Arthritis Rheum. 50, 3994–4001 (2004).
Herrick, A. L. et al. A double-blind, randomized, placebo-controlled crossover trial of the α2C-adrenoceptor antagonist ORM-12741 for prevention of cold-induced vasospasm in patients with systemic sclerosis. Rheumatology (Oxford) 53, 948–952 (2014).
Zhou, Q. & Liao, J. K. Pleiotropic effects of statins. Basic research and clinical perspectives. Circ. J. 74, 818–826 (2010).
Tuuminen, R. et al. Donor simvastatin treatment abolishes rat cardiac allograft ischemia/reperfusion injury and chronic rejection through microvascular protection. Circulation 124, 1138–1150 (2011).
Furukawa, S. et al. Protective effect of pravastatin on vascular endothelium in patients with systemic sclerosis: a pilot study. Ann. Rheum. Dis. 65, 1118–1120 (2006).
Kuwana, M. et al. Increase in circulating endothelial precursors by atorvastatin in patients with systemic sclerosis. Arthritis Rheum. 54, 1946–1951 (2006).
Fava, A. et al. Efficacy of Rho kinase inhibitor fasudil in secondary Raynaud's phenomenon. Arthritis Care Res. (Hoboken) 64, 925–929 (2012).
Thompson-Torgerson, C. S., Holowatz, L. A., Flavahan, N. A. & Kenney, W. L. Rho kinase-mediated local cold-induced cutaneous vasoconstriction is augmented in aged human skin. Am. J. Physiol. Heart Circ. Physiol. 293, H30–H36 (2007).
Neumeister, M. W. et al. Botox therapy for ischemic digits. Plast. Reconstr. Surg. 124, 191–201 (2009).
Van Beek, A. L., Lim, P. K., Gear, A. J. & Pritzker, M. R. Management of vasospastic disorders with botulinum toxin A. Plast. Reconstr. Surg. 119, 217–226 (2007).
Fregene, A., Ditmars, D. & Siddiqui, A. Botulinum toxin type A: a treatment option for digital ischemia in patients with Raynaud's phenomenon. J. Hand Surg. Am. 34, 446–452 (2009).
Montal, M. Botulinum neurotoxin: a marvel of protein design. Annu. Rev. Biochem. 79, 591–617 (2010).
Shibasaki, M. et al. Neurally mediated vasoconstriction is capable of decreasing skin blood flow during orthostasis in the heat-stressed human. J. Physiol. 575, 953–959 (2006).
Morris, J. L., Jobling, P. & Gibbins, I. L. Differential inhibition by botulinum neurotoxin A of cotransmitters released from autonomic vasodilator neurons. Am. J. Physiol. Heart Circ. Physiol. 281, H2124–H2132 (2001).
Smyth, L. M., Breen, L. T. & Mutafova-Yambolieva, V. N. Nicotinamide adenine dinucleotide is released from sympathetic nerve terminals via a botulinum neurotoxin A-mediated mechanism in canine mesenteric artery. Am. J. Physiol. Heart Circ. Physiol. 290, H1818–H1825 (2006).
Niles, W. D. & Malik, A. B. Endocytosis and exocytosis events regulate vesicle traffic in endothelial cells. J. Membr. Biol. 167, 85–101 (1999).
Ma, S. et al. Activation of the cold-sensing TRPM8 channel triggers UCP1-dependent thermogenesis and prevents obesity. J. Mol. Cell Biol. 4, 88–96 (2012).
Wigley, F. M., Wise, R. A., Mikdashi, J., Schaefer, S. & Spence, R. J. The post-occlusive hyperemic response in patients with systemic sclerosis. Arthritis Rheum. 33, 1620–1625 (1990).
Cooke, J. P., Creager, M. A., Osmundson, P. J. & Shepherd, J. T. Sex differences in control of cutaneous blood flow. Circulation 82, 1607–1615 (1990).
Freedman, R. R. & Moten, M. Gender differences in modulation of peripheral vascular adrenoceptors. Ann. Behav. Med. 17, 15–18 (1995).
Bartelink, M. L., De Wit, A., Wollersheim, H., Theeuwes, A. & Thien, T. Skin vascular reactivity in healthy subjects: influence of hormonal status. J. Appl. Physiol. 74, 727–732 (1993).
Bartelink, M. L., Wollersheim, H., Theeuwes, A., van Duren, D. & Thien, T. Changes in skin blood flow during the menstrual cycle: the influence of the menstrual cycle on the peripheral circulation in healthy female volunteers. Clin. Sci. (Lond.) 78, 527–532 (1990).
Eid, A. H. et al. Estrogen increases smooth muscle expression of α2C-adrenoceptors and cold-induced constriction of cutaneous arteries. Am. J. Physiol. Heart Circ. Physiol. 293, H1955–H1961 (2007).
Kim, H., Richardson, C., Roberts, J., Gren, L. & Lyon, J. L. Cold hands, warm heart. Lancet 351, 1492 (1998).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Flavahan, N. A vascular mechanistic approach to understanding Raynaud phenomenon. Nat Rev Rheumatol 11, 146–158 (2015). https://doi.org/10.1038/nrrheum.2014.195
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrrheum.2014.195
This article is cited by
-
Raynaud phenomenon: from GWAS to drug repurposing
Nature Reviews Rheumatology (2024)
-
Efficacy analysis of minimally invasive surgery for Raynaud’s syndrome
BMC Surgery (2023)
-
Vasoreactivity of the optic nerve head, nailfold, and facial skin in response to cold provocation in normal-tension glaucoma patients
BMC Ophthalmology (2023)
-
Non-criteria antiphospholipid antibodies and pediatric rheumatic disease: a case series
Pediatric Rheumatology (2022)
-
Funktionelle akrale Durchblutungsstörungen
Die Innere Medizin (2022)